Comparative Efficacy and Safety of Adalimumab vs Vedolizumab in Managing Moderate-to-Severe Crohn's Disease: A Systematic Review and Meta-Analysis Article (Faculty180)

cited authors

  • Merza, N; Al-Hillan, A; Mansur, S; Merza, F A; Nawras, M; Dahiya, D S; Boujemaa, S; Naguib, T; Kobeissy, A A; Hassan, M; Islam, A; Alastal, Y

published in